Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM449872 (US10703741, Compound I-15) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | US Patent US10703741 (2020) BindingDB Entry DOI: 10.7270/Q2P55RJQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Mus musculus) | BDBM449871 (US10703741, Compound I-14) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | US Patent US10703741 (2020) BindingDB Entry DOI: 10.7270/Q2P55RJQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Mus musculus) | BDBM449861 (US10703741, Compound I-4 | US10703741, Compound I-...) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | US Patent US10703741 (2020) BindingDB Entry DOI: 10.7270/Q2P55RJQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Mus musculus) | BDBM449862 (US10703741, Compound I-5) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | US Patent US10703741 (2020) BindingDB Entry DOI: 10.7270/Q2P55RJQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Mus musculus) | BDBM449859 (US10703741, Compound I-2) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | US Patent US10703741 (2020) BindingDB Entry DOI: 10.7270/Q2P55RJQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM449859 (US10703741, Compound I-2) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 550 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Compounds were solubilized in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | US Patent US10703741 (2020) BindingDB Entry DOI: 10.7270/Q2P55RJQ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528737 (US11198681, Compound I-62) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528739 (US11198681, Compound I-64) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528740 (US11198681, Compound I-65) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528740 (US11198681, Compound I-65) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528744 (US11198681, Compound I-69) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528744 (US11198681, Compound I-69) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528746 (US11198681, Compound I-70) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528746 (US11198681, Compound I-70) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528747 (US11198681, Compound I-71) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528749 (US11198681, Compound I-73) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528754 (US11198681, Compound I-78) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528757 (US11198681, Compound I-81) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528758 (US11198681, Compound I-82) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528760 (US11198681, Compound I-84) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528761 (US11198681, Compound I-85) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528762 (US11198681, Compound I-86) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528764 (US11198681, Compound I-87) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528766 (US11198681, Compound I-89) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528769 (US11198681, Compound I-92) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528778 (US11198681, Compound I-102) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528781 (US11198681, Compound I-105) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Mus musculus) | BDBM528721 (US11198681, Compound I-48) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528791 (US11198681, Compound I-117) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528790 (US11198681, Compound I-115) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528787 (US11198681, Compound I-112) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528719 (US11198681, Compound I-46) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528784 (US11198681, Compound I-108) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528786 (US11198681, Compound I-111) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528719 (US11198681, Compound I-46) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Mus musculus) | BDBM528716 (US11198681, Compound I-43) | UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528716 (US11198681, Compound I-43) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528710 (US11198681, Compound I-37) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528703 (US11198681, Compound I-30) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528701 (US11198681, Compound I-28) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528693 (US11198681, Compound I-20) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM528682 (US11198681, Compound I-9) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Compounds were solubilised in 100% DMSO to achieve 100 mM final compound concentration. Compound stock solutions were stored at RT. A series of dilut... | Citation and Details BindingDB Entry DOI: 10.7270/Q2930XB3 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM501468 (US11026937, Compound I-61) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Assay buffer (as aforementioned): 100 mM Tris-HCl (pH 7.6), 2 mM DTT, 1 mM CaCl2Final concentrations:100 nM hPAD4 enzyme50 μM (8-fold sub-Km) su... | US Patent US11026937 (2021) BindingDB Entry DOI: 10.7270/Q2R78JB0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM501409 (US11026937, Compound I-4) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Assay buffer (as aforementioned): 100 mM Tris-HCl (pH 7.6), 2 mM DTT, 1 mM CaCl2Final concentrations:100 nM hPAD4 enzyme50 μM (8-fold sub-Km) su... | US Patent US11026937 (2021) BindingDB Entry DOI: 10.7270/Q2R78JB0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM501476 (US11026937, Compound I-68) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Assay buffer (as aforementioned): 100 mM Tris-HCl (pH 7.6), 2 mM DTT, 1 mM CaCl2Final concentrations:100 nM hPAD4 enzyme50 μM (8-fold sub-Km) su... | US Patent US11026937 (2021) BindingDB Entry DOI: 10.7270/Q2R78JB0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM501484 (US11026937, Compound I-76) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Assay buffer (as aforementioned): 100 mM Tris-HCl (pH 7.6), 2 mM DTT, 1 mM CaCl2Final concentrations:100 nM hPAD4 enzyme50 μM (8-fold sub-Km) su... | US Patent US11026937 (2021) BindingDB Entry DOI: 10.7270/Q2R78JB0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM501488 (US11026937, Compound I-80) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Assay buffer (as aforementioned): 100 mM Tris-HCl (pH 7.6), 2 mM DTT, 1 mM CaCl2Final concentrations:100 nM hPAD4 enzyme50 μM (8-fold sub-Km) su... | US Patent US11026937 (2021) BindingDB Entry DOI: 10.7270/Q2R78JB0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM501531 (US11026937, Compound I-107) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Assay buffer (as aforementioned): 100 mM Tris-HCl (pH 7.6), 2 mM DTT, 1 mM CaCl2Final concentrations:100 nM hPAD4 enzyme50 μM (8-fold sub-Km) su... | US Patent US11026937 (2021) BindingDB Entry DOI: 10.7270/Q2R78JB0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM501466 (US11026937, Compound I-60) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Assay buffer (as aforementioned): 100 mM Tris-HCl (pH 7.6), 2 mM DTT, 1 mM CaCl2Final concentrations:100 nM hPAD4 enzyme50 μM (8-fold sub-Km) su... | US Patent US11026937 (2021) BindingDB Entry DOI: 10.7270/Q2R78JB0 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Protein-arginine deiminase type-4 (Homo sapiens (Human)) | BDBM501459 (US11026937, Compound I-53) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Padlock Therapeutics, Inc. US Patent | Assay Description Assay buffer (as aforementioned): 100 mM Tris-HCl (pH 7.6), 2 mM DTT, 1 mM CaCl2Final concentrations:100 nM hPAD4 enzyme50 μM (8-fold sub-Km) su... | US Patent US11026937 (2021) BindingDB Entry DOI: 10.7270/Q2R78JB0 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 420 total ) | Next | Last >> |